Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Sexually-acquired HCV in MSM Using PrEP
J Infect Dis; ePub 2018 Nov 20; Price, et al
Interventions are needed to prevent sexually-acquired hepatitis C virus (HCV) infections by men who have sex with men (MSM) using pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection, a recent report concluded. With the introduction of PrEP against HIV, researchers hypothesized that these infections would increase. They found:
- Between 2013 and 2018, 15 likely sexually-acquired HCV infections were diagnosed among 14 MSM using PrEP.
- 87% of these infections were asymptomatic, detected by routine ALT or HCV monitoring.
- Half of the study population reported increasing sex partners and drug use after starting PrEP.
- CDC guidelines for monitoring during PrEP should include regular ALT and HCV testing.
Price JC, McKinney JE, Crouch PC, et al. Sexually acquired hepatitis C infection in HIV-uninfected men who have sex with men using pre-exposure prophylaxis against HIV. [Published online ahead of print November 20, 2018]. J Infect Dis. doi:10.1093/infdis/jiy670.
This Week's Must Reads
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al